PE20080106A1 - Composicion farmaceutica estable de carisoprodol y meloxicam - Google Patents

Composicion farmaceutica estable de carisoprodol y meloxicam

Info

Publication number
PE20080106A1
PE20080106A1 PE2007000064A PE2007000064A PE20080106A1 PE 20080106 A1 PE20080106 A1 PE 20080106A1 PE 2007000064 A PE2007000064 A PE 2007000064A PE 2007000064 A PE2007000064 A PE 2007000064A PE 20080106 A1 PE20080106 A1 PE 20080106A1
Authority
PE
Peru
Prior art keywords
carisoprodol
pharmaceutical composition
meloxicam
stable pharmaceutical
sprains
Prior art date
Application number
PE2007000064A
Other languages
English (en)
Inventor
Regalado Antonio Santiago
Leon Sixto Serafin Espinoza
Original Assignee
Silanes Sa De Cv Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37897453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080106(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Silanes Sa De Cv Lab filed Critical Silanes Sa De Cv Lab
Publication of PE20080106A1 publication Critical patent/PE20080106A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE MELOXICAM EN UNA CANTIDAD EQUIVALENTE DE 7,5-15 mg Y CARISOPRODOL EN UNA CANTIDAD EQUIVALENTE DE 200-600 mg. DICHA COMPOSICION ES SEGURA PARA LA ADMINISTRACION DE CORTO TIEMPO (15 DIAS), NO PROVOCA DANO INTESTINAL SIENDO UTILES EN EL TRATAMIENTO DE DOLORES MUSCULARES O ESQUELETICOS TALES COMO TORTICOLIS, TORCEDURAS, ESGUINCES, LUXACIONES, DISTENSIONES MUSCULARES, TENDINOSAS Y LIGAMENTOSAS, DOLOR POST-TRAUMATICO, FRACTURAS Y DEMAS PROCESOS RELACIONADOS CON INFLAMACION Y CONTRACTURA
PE2007000064A 2006-01-20 2007-01-19 Composicion farmaceutica estable de carisoprodol y meloxicam PE20080106A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA06000760A MXPA06000760A (es) 2006-01-20 2006-01-20 Composicion farmaceutica estable de carisoprodol y meloxicam.

Publications (1)

Publication Number Publication Date
PE20080106A1 true PE20080106A1 (es) 2008-04-27

Family

ID=37897453

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000064A PE20080106A1 (es) 2006-01-20 2007-01-19 Composicion farmaceutica estable de carisoprodol y meloxicam

Country Status (7)

Country Link
US (1) US20070213324A1 (es)
EP (1) EP1810674A1 (es)
AR (1) AR059081A1 (es)
CO (1) CO5940095A1 (es)
GT (1) GT200700005A (es)
MX (1) MXPA06000760A (es)
PE (1) PE20080106A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1103205A2 (pt) * 2011-06-03 2014-02-25 Eurofarma Lab Ltda Composição farmacêutica oral e uso da composição farmacêutica oral
MX2018013458A (es) * 2018-11-05 2019-07-25 Federico Amezcua Amezcua Composicion farmaceutica que comprende la combinacion de un inhibidor selectivo de la ciclooxigenasa 2 y un carbamato derivado de la guaifenesina para el tratamiento del dolor, inflamacion y contractura muscular.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780463A (en) * 1984-12-26 1988-10-25 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
AU3990895A (en) * 1995-12-05 1997-06-27 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
US20040204413A1 (en) 2001-01-26 2004-10-14 Joaquina Faour Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant
GB0224198D0 (en) * 2002-10-17 2002-11-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
MXPA06000760A (es) 2007-07-19
AR059081A1 (es) 2008-03-12
CO5940095A1 (es) 2008-07-31
EP1810674A1 (en) 2007-07-25
GT200700005A (es) 2007-08-28
US20070213324A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
CL2008001268A1 (es) Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor.
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
SV2011003901A (es) Compuestos de arilo con sustituyentes heterocíclicos como inhibidores de hif
DOP2009000155A (es) Derivados de hetero-pentaciclo-fenilo fusionados, composicion farmaceutica que los comprende y usos para preparar un medicamento util para el tratamiento de una condicion mediada por p38
AR047928A1 (es) Derivados de tetrahidropiridoindol
PE20170302A1 (es) Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
DOP2006000057A (es) Composición farmaceútica para el tratamiento del cáncer
AR040032A1 (es) C-aril-glucosidos como inhibidores de sglt2 y metodo
AR022076A1 (es) Composicion antioxidante constituida por acetil l-carnitina y acido alfa-lipoico para mejorar el aprovechamiento metabolico de la glucosa
CR10167A (es) "uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de dolor"
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
AR109263A2 (es) Composición que comprende moxidectina
BR112013025878A2 (pt) composição farmacêutica e método para produzir uma composição farmacêutica
GB2456475A (en) Composition for the treatment of skin conditions
BRPI0414386A (pt) composto, métodos para fabricação do mesmo, para tratamento ou prevenção de uma doença, para ativação da função de er em uma célula óssea, para inibição de função de er em uma célula, para inibição da expressão de il-6, para inibição do crescimento de uma célula neoplásica expressando er, para prevenção de espermatogenese, para prevenção de um efeito reprodutivo adverso associados com exposição a uma falta de equilìbrio hormonal natural ou quìmica ambiental, e, composição
BRPI0511398A (pt) composição farmacêutica anidra para o tratamento da psorìase e uso de um agente siliconado
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
DK1677806T3 (da) Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
PE20080106A1 (es) Composicion farmaceutica estable de carisoprodol y meloxicam
AR045263A1 (es) Metodo, kit y composicion farmaceutica para tratar infecciones virales
RU2011148355A (ru) Применение аллопуринола для ладонно-родошвенного синдрома
CY1115914T1 (el) Δερματολογικες συνθεσεις που περιεχουν συνδυασμο υπεροξυγονουχων λιπιδιων και ψευδαργυρου και οι χρησεις τους ιδιαιτερα στη θεραπεια του ερπητα
PT1220676E (pt) Prevencao do cancro colorrectal
BRPI0415051A (pt) compostos antagonistas do hormÈnio concentrador de melanina e suas composições farmacêuticas

Legal Events

Date Code Title Description
FC Refusal